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     Since the uterine is a sensitive tissue to steroid hormones, the aim of the present study was to 
investigate the effects of 17β-estradiol (E2) and progesterone (P4) alone or in combination on 
morphological and morphometrically parameters of ovariectomized mouse uterus. 
Adult virgin female mice (8-10 weeks old)were ovariectomized and treated with E2, P4, E2 followed by 
P4 and the oil vehicle alone for 5-days period. Uterine tissue was removed, and processed for histology 
assessment. The total uterine diameter were significantly higher (P < 0.05) following E2 treatment and 
Maximum diameter of uterine lumen, myometrium and endometrium were recorded after this treatment 
regimen. Sequential treatment with oestradiol and then progesterone caused both mitotic activity and cell 
degeneration. P4 treatment induced signs of active secretion in the endometrium glands and symptoms of 
degeneration and cell death. Estradiol treatment induced growth of uterine tissue. Subsequent treatment 
with progesterone stimulated uterine tissues to reach maximum size and maturity which is necessary to 
modify the uterus in preparation for pregnancy. 
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INTRODUCTION 
    The uterine is a dynamic tissue that 
undergoes cycles of proliferation, differentiation 
shedding (humans and primates) or apoptosis 
(rodent)which are affected by ovarian sex 
steroids; 17β-estradiol (E2) and progesterone 
(P4) during each reproductive cycle[1]. 
The E2 and P4 cause some molecular and 
cellular changes in uterine tissue [2] which are 
mediated by their receptors [3, 4]. Changes in 
the ratio of  E2 to P4 during the oestrous cycle 
reflected in the patterns of uterine tissue such as 
cellular proliferation, angiogenesis, extracellular 
matrix remodelling, cell differentiation [1] and 
size [3-6]. E2 and P4 prepare the endometrium 
to establish successful implantation [7]. E2 
stimulate epithelial (glandular and luminal) and 
stromal cell proliferation [8] and induced 
expression of E2 and P4 receptors [9].WhileP4 
is essential for appropriate secretory 
transformation of the glands and stromal 
decidualization to facilitate implantation [10]. It 
has been shown that removal of endogenous E2 
and P4 leads to thin atrophic endometrium with 
few glands, considerably reduced luminal 
epithelium, dense stroma and apoptosis of 
estrogen-sensitive cells [11]. Administration 
ofE2 results in regeneration of the endometrium 
with proliferation of epithelial and stromal cell, 
increase the number of glands and stromal 
edema [11]. Priming mice with E2 followed by 
P4 treatment induce decidualization which can 
be reversed by removal P4 [12]. 
Since the uterine is a sensitive tissue to steroid 
hormones the present study was undertaken to 
investigate effects of exogenous E2and P4 alone 
or in combination inovariectomizedmice on 
morphologic and morphometric parameters of 
uterus.  
 
MATERIALS AND METHODS 
Reagents 
      All reagents were purchased from Merck-
Germany unless otherwise stated. 
Animals and surgical procedures 
      In this experimental study, adult virgin 
female National Medical Research Institute 
(NMRI) mice(8-10 weeks old; n= 45) supplied 
from Iran Pasteur Institute were cared for and 
used according to the guide of laboratory 
animals of our university that fulfils and follows 
declaration of Helsinki as revised in Tokyo 
 




2004. They were housed under controlled 
environmental conditions at 24 ± 2°C and 
relativehumidity of 44 ± 2% with a 12-hour 
dark/12 hour light cycle (light on at 7:00 AM) 
and provided with food and water adlibitum for 
at least one week before use. Animals were 
weighed before and after the 
experiment.Estrous cycle of animals were 
determined by evaluation of vaginal smears and 
those which were on diestrus phase selected for 
next step[13]. Anesthesia was induced by 
intraperitoneal injection ofxylazineand ketamine 
(10 and 100 mg/kg/BW respectively). When the 
animals ceased to react, they were placed on an 
operating board. The females were bilaterally 
ovariectomized by the paralumbal route[14]. 
Experimental Design 
Two weeks after surgery, the mice were 
randomly distributed into five groups as follow: 
1) Control: Ovariectomized mice without any 
treatment, 2) Sham: Ovariectomized mice 
treatedwith drug vehicle ( 40µl; Sigma 
Aldrich,St. Louis, MO) 3) E2: Ovariectomized 
mice treated with E2, (8 µg/kg/BW; Sigma- 
Aldrich,St. Louis, MO) 4) P4: Ovariectomized 
mice treated with P4, (50 µg/g/BW; Sigma 
Aldrich,St. Louis, MO)  and  5)E2&P4: 
Ovariectomized micetreated with combination 
of E2 and P4, which were received E2  (8 
µg/kg/BW) on the first day and P4 (50 
µg/g/BW) from the second day to the fifth day 
[15]. 
Vehicle and route of hormone administration 
    In the present study, we used sesame oil, as a 
vehicle for steroid hormones. The vehicle 
(Sham; 40 µl) or a steroid hormone (40 µl) were 
injected subcutaneously using a 1 ml glass 
tuberculin syringe fitted with a 29-gauge needle. 
Animals were treated for 5 days. 
Tissue preparation and histological techniques 
The day after the last injection, sampling was 
carried out on the one-third of the uterinehorns, 
then were placed in fresh buffered formalin for 
fixation, washed and dehydrated in an ethanol 
series of ascending concentration, cleared in 
xylene, and embedded in paraffin 
wax.Afterwards, transverse cross-sections of 5 
µm in thick were obtained, mounted on 
microscope slides, after dewaxing with xylene 
and hydration in an ethanol series of descending 
concentrations, were stained with hematoxylin 
and eosin as described previously (RUSSELL 
WESTWOOD , 2008).  
Morphological and morphometrically 
evolutions  
Five slides from different mice within each 
group and twodifferent fields of each slides 
were assessed by using a light microscope 
(Nikon, Japan). The evaluationcriteria on each 
slide were as follow: total thickness (µm) of the 
uterine wall, thickness of endometrium and 
myometrium (µm),thenumbers of stromal cells, 
endometrial glands, blood vessels, connective 
tissue and epithelium. For this purpose were 
evaluated. 
Statistical analysis  
     All data were presented as mean ± SD. 
Statistical analysis was performed using SPSS-
ver.16 software package for windows (SPSS 
Inc, Chicago, IL, USA). For each analysed 
variable, data were submitted to normality 
analysis (Kolmogorov-Smirnov test) and One-
way analysis of variance (ANOVA) and 
Tukey's HSD Post Hoc test was used to 
compare the groups. A significance level of 




     Comparison of mice weight, revealed no 
significant differences before and after 
treatment (Table1; P>0.05). Uterus of the 
control group was small and inactive and 
showed a slit like lumen.Also, compaction of 
stromal cells was seen.Eosinophilic cytoplasm 
and variety of nuclear morphology were 
detectedand. Dead cells were observed 
sporadically. Some glands with small diameter 
and the few number of blood vessels was 
observed in the stroma. Perimetrium layer and 
circular and longitudinal muscles layers of 
myometrium were thin. (Figure 2). There was 
no different change of histological criteria of 
uterine tissues in shame group as compared with 
the control group(Figure2). The histology 
properties of E2 treated group were as follow: 
The uterus lumenhad multiple folds and 
decreased space. Also, stromaedema and 
cellular compaction were observed. There was 
remarkable degeneration and necrosis of 
epithelial cells. Mitotic activity was very 
low.The musculature of the uterus was 
in several layers. Oblique muscles between the 
circular and longitudinal muscle layers can be 
clearly seen. Vasculogenesis of endometrium 
and myometrium were increased (Figure 2). 
 
 





Figure 1: The Photomicrographs of whole uterine tissue in control (A), E2 (B), P4 (C), E2&P4 (D) and oil vehicle(E) 
treated groups to reveal lumen space and diameter of different part of uterine wall. 
 
 
Figure 2: The photomicrographs of uterine tissue cross section in control (A), E2 (B),P4 (C), E2&P4 (D) and oil 
vehicle(E) treated groups 
 
Table1: Body weights of mices in experimental groups 
Group BW(g) AW(g) PW(g) SW(g) 
Control 28.55±1.62 28.01±2.092 33.57±1.83
ab 
33.57±1.83 
E2 29.61±2.16 28.98±2.12 33.94±2.17
a 
33.56±2.04 
P4 28.06±2.06 27.19±1.97 32.19±2.06
ab 
32.07±2.14 
E2&P4 28.45±3.71 27.92±3.56 33.13±2.99
ab 
33.98±2.86 
Oil vehicle 29.83±2.09 29.57±1.76 30.88±2.01
b 
32.38±2.89 
Data are expressed as Mean±SD 
E2:17β-Estradiol, P4: Progesterone, BW: body weight before of ovariectomized, AW: body weight after ovariectomized, 
PW: Pre-treatment body weightt ,SW: Post-treatment body weight (before Sacrifice). 
Different superscripts in the same column reflect different levels of significant difference (p<0.05). 
 
 





Table2. Diameter of whole and different layers of uterine tissue  





















































































Data are expressed as Mean±SD 
E2:17β-Estradiol, P4:Progesterone, TD:Total Diameter, RLP:Right Lumen-Perimetrium, LPL: Left Lumen-Perimetrium, 
RLE: Right Lumen-Endometrum, LEL: Left Lumen-Endometrum, RMP: Right Myometrium-Perimetrium, LMP: Left 
Myometrium-Perimetrium. 
Different superscripts in the same column reflect different levels of significant difference (p<0.05). 
 
 
The P4 treated group histology evaluation 
showed, small, avascular slit-like lumen. The 
stromal cellular compaction were similar to 
control group. Also, there were eosinophilic 
stromal cells. Endometrial glands with signs of 
active secretion were seen. Symptoms of 
degeneration and cell death were observed 
irregularly. Myometrium layer was thin, the 
space between the circular and longitudinal 
layers is narrower and thickness of obliquely 
muscle layer was reduced (figure 2).Treatment 
with E2 followed by P4 induced both mitotic 
activity, cell degeneration andstromal cellular 
compactionin different layer of uterus whereas, 
nucleus of cells areeuchromatin and larger than 
other groups (figure 2). 
The total uterine diameters of the E2 and sham 
groups were significantly increase in 
comparison to other groups (Table 2; p < 0.05). 
Whereas, there were no significant differences 
among total uterine diameter of the P4, E2&P4 
and control groups.  
The diameter of uterine lumen of E2 and sham 
groups were significantly greater than other 
groups (p < 0.05). The diameters of 
myometrium in the E2 and sham groups were 
significantly increase in comparison to other 
groups (Table 2; p < 0.05).  
The mean numbers of stromal cells per sections 
of uterine tissue in all groups were counted and 
summarized in Table2.The assessment of mean 
numbers of stromal cells showed that the mean 
numbers of stromal cells of the E2 &P4 and 
sham groups was the highest and lowest 
respectively (p<0.05). There was no significant 
differenceamong the mean numbers of stromal 
cells of P4, control and E2 groups (p>0.05). 
 
DISCUSSION 
    In the intact mouse the cellular alterations of 
uterus during the reproductive cycle are regulated 
by the levels of circulating ovarian sex 
steroidssuch as E2 and P4[6]. These steroids can 
affect uterine cell proliferation and tissue 
remodeling, which are essential for preparation of 
the uterus to successful implantation and sustainof 
embryonic development [3, 5]. It seems that the 
ovariectomized mouse model is appropriate for 
evaluation of the effect of the exogenous steroid 
hormones on uterus tissue. 
The present study showed that steroid hormones 
replacement regimen in ovariectomized mouse 
model affect the uterine morphology and 
histologyso that, total uterine, endometrium and 
myometrium diameters in E2treated group was 
increased significantly than other groups. These 
results may be due to the effect of E2 on the 
increase of the number and size of the uterine 
cells.  
It appears that E2 affects uterus initially in the 
short period (24 h after injection) through the 
induction the expression of anti-apoptotic genes. 
However, It has been demonstrated that E2 by 
increase uterine RNA content and protein lead to 
an increase in cell size in the long term (48 h after 
injection) [3]. Also E2, down-regulating the 
expression of pro-apoptotic genes and cell cycle 
inhibitors simultaneously, whereas, induce or 
activate the cell cycle stimulators [10] which in 
turn, regulates proliferation, growth and 
endometrial cell survival [16]. It has been shown 
that the major effect of E2 on uterine size is on 
tissue hypertrophy (cell size as reflected by RNA/ 
DNA and protein/ DNA ratios) rather than tissue 
hyperplasia (changes in DNA content) [3].  
 
 




 It has been shown that E2 affects endometrium 
with activation of cell genome by its receptor in 
a target cell nucleus [6], so that, stimulates 
proliferation of endometrial epithelial and 
stromal cells through up regulatingproduction 
and secretion of transforming growth factor α 
(TGFα), epidermal growth factor (EGF) and 
insulin-like growth factor-1 (IGF-1) [17]. 
Although, in the absence of the E2, the division 
rate of the endometrial cells (luminal and 
glandular epithelial cells) is very low [18]. It 
has been shown that effects of E2on uterine 
atrophied tissues of ovariectomized ewes was 
greater than normal uterine tissues during the 
estrous cycle [3]. 
Results of the present study demonstrate that P4 
administration alone or in combination with E2 
to ovariectomized mice had no effect on uterine 
diameter,whereas increased the cellularity of 
stroma. In this regard, it has been known that E2 
induce proliferation of epithelium (luminal and 
glandular), while P4 reverse this effects directly 
[1]. It seems that P4 inhibits the proliferative 
effects of E2 on epithelial cells through 
induction of proteins secretion from stromal 
cells ]19] which in turn lead to differentiatethe 
epithelial cells to prepare uterine for 
implantation [20]. It has been investigated that 
the anti-Proliferative effect of P4 on 
endometrial epithelium is mediated via the 
progesterone receptor-A isoform ]21]. P4 
changes uterine stromal cells [22], to stimulate 
predecidual changes around spiral arterioles 
below the luminal epithelium which in turn 
prime the uterus to respond to decidualizing 
stimuli [16]. On the other hand, E2 not only 
decrease P4 receptor levels in the luminal 
epithelium but also, increase P4 receptor levels 
in the stroma and myometrium [23]. Thus, it 
seems that in the E2&P4 combination treated 
group, E2 increased expression of P4 receptor 
in the uterine stroma which in turn provide ideal 
conditions for P4 to increase stromal cells 
proliferation [24]. In addition, the results of this 
study  showed,  treatment  of  ovariectomized  
mice with E2 leads to an increase in the number 
of small glands with no signs of secretion, while 
in the P4 treated group the number of enlarged 
glands with signs of active secretion were 
increased. It has been known that, E2 have main 
role in the mediation of gland formation 
however,the treatment of ovariectomized rat 
with E2 induce uterine epithelial hypertrophy[1, 
15, 18]. Also, in the E2 treated group, diameter 
of blood vessels ofthe endometrium and 
myometrium were increased and more 
distributed than other groups. It has been 
investigated that E2 can enhance angiogenesis 
and vasculogenesis through increasing the 
number of endothelial progenitor cells [25]. On 
the other hand, P4 increase E2-induced 
angiogenesis via increase the expression of 
endothelial nitric oxide synthase [26].  
It appears that P4 inhibits expression of E2 
receptors of uterine vascular endothelium, 
which in turn decreases E2-induced 
angiogenesis [25].  
This is in agreement with our results in E2&P4 
treated and P4 alone groups which there was no 
increase of distribution of blood vessels. It 
seems that both E2 and P4 have paradoxical 
actions, so that under different conditions, both 




      In conclusion, evidence of the present study 
indicate that E2 induced growth of uterine 
tissue. While, subsequent treatment with P4 
stimulate uterine tissues to reach maximum size 
and maturity which is necessary to modify the 
uterus for pregnancy preparation. Also, this 
detail provide reasonable and practical 
guidelines for histopathology studies of the 
effects of steroid hormone on uterine tissue.  
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